vTv Therapeutics VTVT
$ 14.88
6.97%
Quarterly report 2023-Q2
added 08-11-2023
Country |
USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Stephen Holcombe |
Employees in the company |
26 |
Shares |
- |
Market Cap[1] |
$ 44.8 M |
EBITDA (LTM) |
$ -23.5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.